ElsevierDrugInformation

Pemivibart Injection

Learn more about Elsevier’s Drug Patient Education today! Empower and engage your patients to use medication safely.

Nov.18.2024

Pemivibart Injection

What is this medication?

PEMIVIBART (pem iv i bart) reduces the risk of COVID-19. It does not treat COVID-19. It is still possible to get COVID-19 after receiving this medication, but the symptoms may be less severe or not last as long. It works by helping people with a weak immune system fight off a future infection. It is a monoclonal antibody. The FDA has allowed the emergency use of this medication.

This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.

How should I use this medication?

This medication is infused into a vein. It is given by your care team in a hospital or clinic setting.

Talk to your care team about the use of this medication in children. While it may be given to children as young as 12 years, precautions do apply.

Overdosage: If you think you have taken too much of this medicine contact a poison control center or emergency room at once. NOTE: This medicine is only for you. Do not share this medicine with others.

What side effects may I notice from receiving this medication?

Side effects that you should report to your care team as soon as possible:

Allergic reactions or angioedema—skin rash, itching or hives, swelling of the face, eyes, lips, tongue, arms, or legs, trouble swallowing or breathing
Infusion reactions—chest pain, shortness of breath or trouble breathing, feeling faint or lightheaded
Painful swelling, warmth, or redness of the skin, blisters or sores at the infusion site

Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):

Fatigue
Flu-like symptoms—fever, chills, muscle pain, cough, headache, fatigue
Headache
Nausea

This list may not describe all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Where should I keep my medication?

This medication is given in a hospital or clinic. It will not be stored at home.

NOTE: This sheet is a summary. It may not cover all possible information. If you have questions about this medicine, talk to your doctor, pharmacist, or health care provider.

What should I tell my care team before I take this medication?

They need to know if you have any of these conditions:

Received a COVID-19 vaccine
An unusual or allergic reaction to pemivibart, other medications, foods, dyes, or preservatives
Pregnant or trying to get pregnant
Breastfeeding

What may interact with this medication?

Interactions have not been studied.

This list may not describe all possible interactions. Give your health care provider a list of all the medicines, herbs, non-prescription drugs, or dietary supplements you use. Also tell them if you smoke, drink alcohol, or use illegal drugs. Some items may interact with your medicine.

What if I miss a dose?

Keep appointments for follow-up doses. It is important not to miss your dose. Call your care team if you are unable to keep an appointment.

What should I watch for while using this medication?

Your condition will be monitored carefully while you are receiving this medication. Visit your care team for regular health checks.

Tell your care team if you have received a COVID-19 vaccine in the last 14 days. This medication should be given at least 14 days after your vaccine.